Ravulizumab: a novel C5 inhibitor for the treatment of...

Therapeutic Advances in Hematology 2019 / 01 Vol. 10

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Stern, Robert M., Connell, Nathan T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Therapeutic Advances in Hematology
DOI:
10.1177/2040620719874728
Date:
January, 2019
File:
PDF, 338 KB
english, 2019
Conversion to is in progress
Conversion to is failed